Skip to main content

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates

Explore URMC


Feldon Lab

Steven E. Feldon, MD - Chairman

  • Chairman - Department of Ophthalmology (SMD, Primary Administrative)
  • Professor - Department of Ophthalmology (SMD, Primary Appointment)
  • Professor - Department of Center for Visual Science (RC)
  • Board Certified Specialty | American Board of Ophthalmology
  • MBA | Business Or Commerce | Univ of Southern California (1997)
  • MD | Medicine | Einstein College Medicine (1973)

Research Overview

Multidisciplinary collaborations are a key to the successful enhancement of eye health. The University of Rochester Medical Center and the Flaum Eye Institute provide an ideal environment for this work.

Graves' Disease

One example of current multidisciplinary investigations is the Graves’ disease collaboration between Steven E. Feldon, M.D., an orbital disease specialist, and Richard Phipps, Ph.D., a researcher who specializes in the study of the biology of fibroblasts (connective tissue cells involved in thyroid eye disease).

Many Graves’ disease patients—especially women who smoke—will develop thyroid eye disease, a condition that causes disfiguring bulging eyes, corneal drying, optic nerve inflammation, blurry vision, and even blindness. An inflammatory process associated with the disease induces structural cells behind the eye called fibroblasts to make too much connective tissue protein. The fibroblasts also convert into fat-like cells. The combination of excessive connective tissue and accumulating fatty tissue pushes the eye out of the eye socket, causing disfigurement, double vision, and vision loss.

View Dr. Feldon's publications